Parkinson’s disease can start with very subtle changes, but catching the early signs might make a difference in treatment.

Parkinson's disease has been getting increased attention in the media, but misinformation abounds. Here, a Parkinson's expert ...

Parkinson’s disease affects 127,000 people in the UK and 7.5 million ... of metabolites that we can mine to distinguish healthy patients from those in the early stages of Parkinson’s. In parallel, ...

The Mount Sinai Health System spinout has developed an artificial intelligence-powered digital pathology system that it says can accurately diagnose Parkinson's in the early stages, when symptoms ...

Sept 26 (Reuters) - AbbVie's (ABBV.N), opens new tab drug met the main goal in a late-stage trial when tested in patients with early Parkinson's disease, the company said on Thursday. Patients ...

NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel ...

ATH434 shows promise as a disease-modifying therapy for MSA - - ATH434-202 Phase 2 interim data demonstrate stabilization of clinical symptoms and biomarkers in clinical responders - MELBOURNE, ...

The preparations for the regulatory submission for early commercialization in Canada follows ... which include amyotrophic ...